Dorsa Pharmaceutical Co.

Dorsa Pharma was established in 1998 by a group of experienced scientists who aimed to provide products that meet global standards. After obtaining all the necessary permits and licenses, the company became fully operational in 2009. Dorsa Pharma is a progressive manufacturing entity that specializes in high-quality generic drugs, APIs, biosimilars, and pharmaceutical products. It is backed by a strong R&D department and some of the best experts in the pharmaceutical industry. As a member of Tavan Pharmaceutical Holding, we benefit from a complete value chain that can offer our partners and customers both local and global solutions. Dorsa Pharma is committed to promoting diversity and continuously improving quality and customer satisfaction through policies that encourage a culture of excellence. We achieve this by increasing production, productivity, and the use of advanced technology and equipment. We prioritize organizing our human capital, developing employee capabilities, managing risks, and preserving the environment. Our team consists of scientists from diverse fields, each with several years of experience in pharmaceutical product development and quality control. Currently, Dorsa Pharma employs over 300 qualified personnel, and we plan to expand our team to 400 in the near future.